PharmaBoardroom

Interview: Philippe Sollie – Founder & Managing…

Philippe Sollie reveals the inspirations behind Flen Pharma and how approaching dermatology from a pharmaceutical background has proved beneficial in…

Interview: Augusto Mitidieri – CEO, Sintetica, Switzerland

Sintetica, Switzlerland’s longtime leader in local anesthesia and pain relief with development efforts in neuromodulation, started an ambitious…

Interview: Iwer Baecker – Managing Director, Bayer Ireland

Iwer Baecker, MD of Bayer Ireland, outlines the Irish affiliate’s impressive growth in the past few years, the strategy of New Bayer and how it…

Mexico Facts and Figures Snapshot

This chart gives an insight into the phenomenal importance of the pharmaceutical industry to Mexico, in terms of both monetary value and employment…

Interview: Francisco Rodriguez – General Manager Mexico…

Francisco Rodriguez, general manager Mexico and Latin America at Mundipharma, provides an overview of the customized market approach that has allowed…

Why the J&J Takeover of Actelion Looks Unlikely

Johnson & Jonhson’s interest in taking over the Swiss biotech group Actelion has been confirmed, with the Wall Street Journal estimating that a…

Interview: Alvin So – Country Division Head, Bayer Consumer…

Alvin So, Bayer Consumer Health Country Division Head, discusses Bayer’s commitment in Consumer Health in the Philippines. He also discusses his…

Richard Saynor – SVP, Classic & Established Products,…

In an exclusive interview with Richard Saynor at GSK, he outlines the growth of the CEP portfolio in emerging markets and highlights the opportunities…